Medical Research News

RSS

Study sheds light on neurologic symptoms caused by SARS-CoV-2 infection

Researchers in Australia and Finland have provided important insights into how infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – might affect nervous system circuitries and cause neurologic symptoms.

6 Sep 2021

Study reveals Pfizer/BioNTech and Oxford/AstraZeneca COVID-19 vaccine efficacy and immune response in clinically vulnerable individuals

The current study found that a strong S-antibody response occurs following complete vaccination with two different COVID-19 vaccines.

6 Sep 2021

Polygenic risk score no better at predicting psychosis outcomes than written reports, study finds

With the help of cutting-edge computer programs, researchers at the Icahn School of Medicine at Mount Sinai went through the genetic and medical records of more than 8,000 schizophrenia patients.

6 Sep 2021

College-educated women more likely to have a first child outside of marriage

College-educated women are much more likely than ever before to have a first child outside of marriage, a new Johns Hopkins University study finds.

6 Sep 2021

Researchers uncover a key role for the biological clock in asthma

For hundreds of years, people have observed that asthma severity often worsens in the nighttime. One longstanding question has been to what degree the body's internal circadian clock - as opposed to behaviors, such as sleep and physical activities - contributes to worsening of asthma severity.

6 Sep 2021

Study investigates the obstacles faced by undocumented immigrants in accessing health services

A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.

6 Sep 2021

COVID-19 presents a higher risk of blood clots than vaccination

The current study found that people were at a slightly higher than normal risk of blood clots after receiving Oxford-AstraZeneca and Pfizer vaccines.

6 Sep 2021

Study finds an increase in depression symptoms among UK adults aged 50-plus during the pandemic

The mental health of UK adults over the age of 50 has been significantly compromised by the Covid-19 pandemic, with females and those in urban areas affected the most, reveals a new study from the University of Surrey.

6 Sep 2021

Patients who contract SARS-CoV-2 Delta variant more likely to be hospitalized than those with Alpha

Recently, researchers found the risk of being hospitalized was two times higher for people with the Delta variant as compared to those with the Alpha variant.

6 Sep 2021

Study: 7.8% of young and middle-aged Austrians suffer from pathological insomnia

Chronic insomnia is widespread and leads to generally poor physical and mental health and has a high societal cost. General data on insomnia from Austria, including the help-seeking behaviour of those affected, have been lacking until now.

6 Sep 2021

Prognostic impact of common type of liver cancer depends on tumor size, research reveals

Researchers at the Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine have shown that the prognostic impact of hepatocellular carcinoma (HCC), the most common type of liver cancer, is dependent on tumor size.

6 Sep 2021

Researchers use hair cortisol test to detect the impact of COVID-19 on stress levels in families

Researchers at NYU Abu Dhabi, in collaboration with Global TIES for Children and researchers at University of California Davis (Paul Hastings and Lindsey Partington) as well as Hashemite University in Jordan (Rana Dajani), have used a hair cortisol test to detect the impact of COVID-19 on stress levels in families.

6 Sep 2021

Delta variant has a more diverse repertoire of mutations than other variants

In a paper, nearly 2 million SARS-CoV-2 genomes from around the world were analyzed, finding great diversity within the delta variant that exceeds that observed in the more widely spread alpha variant.

6 Sep 2021

Decreased COVID-19 vaccine efficacy amongst IBS patients receiving anti-TNFα drugs

In a paper recently uploaded to the preprint server medRxiv* by Edelman-Klapper et al., the efficacy of the mRNA vaccine is examined amongst IBD patients and compared with healthy volunteers, finding reduced efficacy amongst those receiving anti-TNFα medication.

6 Sep 2021

mRNA COVID-19 vaccine protection wanes after six months: a wide-scale study of the population of Qatar

In a paper recently uploaded to the preprint server medRxiv* by Chemaitelly et al. (August 27, 2021), the long-term effectiveness of the mRNA vaccines is analyzed amongst the Qatar population. The study observed waning protection against infection around six months post-vaccination but lasting protection from death and hospitalization.

6 Sep 2021

Reduction in infectious SARS-CoV-2 shedding in vaccine breakthrough infections

In a paper recently uploaded to the preprint server medRxiv*, breakthrough infections are compared with infections in immunologically naïve individuals

6 Sep 2021

Is the SARS-CoV-2 Lambda variant more vaccine-resistant than the Delta variant?

Researchers in the USA and China recently published a report in which they discussed the potential factors that confer high infectivity and immune resistance on the Delta and Lambda variants.

6 Sep 2021

Characterization of SARS-CoV-2 viral trajectory

In a study available on the preprint server medRxiv* researchers aimed to characterize early viral shedding in patients with incident infection. Read more here.

6 Sep 2021

Israeli study on viral load, Delta infections, vaccinations and boosters

Scientists from Israel have recently explored the effectiveness of two-dose and three-dose regimens of the BNT162b2 coronavirus disease 2019 (COVID-19) vaccine (Pfizer/BioNTech) to reduce viral load in breakthrough infections caused by the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

6 Sep 2021

Post-exposure prophylaxis with monoclonal antibodies may reduce health system burden in the US

In a study conducted at the University of Washington, USA, the researchers assert that post-exposure prophylaxis with monoclonal antibodies could improve the clinical outcomes and health system costs regarding coronavirus disease (COVID-19). The study is currently available on the medRxiv* preprint server.

6 Sep 2021

Medical Research News

Study sheds light on neurologic symptoms caused by SARS-CoV-2 infection

Study reveals Pfizer/BioNTech and Oxford/AstraZeneca COVID-19 vaccine efficacy and immune response in clinically vulnerable individuals

Polygenic risk score no better at predicting psychosis outcomes than written reports, study finds

College-educated women more likely to have a first child outside of marriage

Researchers uncover a key role for the biological clock in asthma

Study investigates the obstacles faced by undocumented immigrants in accessing health services

COVID-19 presents a higher risk of blood clots than vaccination

Study finds an increase in depression symptoms among UK adults aged 50-plus during the pandemic

Patients who contract SARS-CoV-2 Delta variant more likely to be hospitalized than those with Alpha

Study: 7.8% of young and middle-aged Austrians suffer from pathological insomnia

Prognostic impact of common type of liver cancer depends on tumor size, research reveals

Researchers use hair cortisol test to detect the impact of COVID-19 on stress levels in families

Delta variant has a more diverse repertoire of mutations than other variants

Decreased COVID-19 vaccine efficacy amongst IBS patients receiving anti-TNFα drugs

mRNA COVID-19 vaccine protection wanes after six months: a wide-scale study of the population of Qatar

Reduction in infectious SARS-CoV-2 shedding in vaccine breakthrough infections

Is the SARS-CoV-2 Lambda variant more vaccine-resistant than the Delta variant?

Characterization of SARS-CoV-2 viral trajectory

Israeli study on viral load, Delta infections, vaccinations and boosters

Post-exposure prophylaxis with monoclonal antibodies may reduce health system burden in the US

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News